DOI QR코드

DOI QR Code

Quantitation and Validation of Atorvastatin using HPLC-UV

  • Published : 2007.06.21

Abstract

A reversed phase HPLC analysis of atorvastatin (AS) standard solution was performed using diclofenac (DF) as internal standard. Column oven temperature, flow rate and the composition of the mobile phase were varied in order to determine a practical system setup using a C18 column and UV detector. Two C18 columns of different length were compared regarding their influence on the AS peak shape. Based on these preliminary experiments a validation study was performed utilizing a C18 column at $62^{\circ}C$ with a mobile phase consisting of sodium phosphate buffer (0.05 M, pH 4.0), methanol and acetonitrile (40:50:10, v/v/v). The detection limit for AS was $0.1{\mu}g/ml$ and inter- and intra-day calibration curves were linear over a concentration range of $0.2-50{\mu}g/ml$. Accuracy and precision were satisfactory in the AS concentration range of $0.5-50{\mu}g/ml$.

Keywords

References

  1. S. Erturk, A. Onal and S.M. Cetin, Analytical methods for the quantitative determination of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in biological samples, J. Chromatogr. B, 793, 193-205 (2003) https://doi.org/10.1016/S1570-0232(03)00314-3
  2. S. Erturk, E. S. Aktas, L. Ersoy and S. Ficicioglu, An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets, J. Pharm. and Biomed. Anal., 33, 1017-1023 (2003) https://doi.org/10.1016/S0731-7085(03)00408-4
  3. X.-S. Miao and C.D. Metcalfe, Determination of cholesterol-lowering statin drugs in aqueous samples using liquid chromatography - electrospray ionization tandem mass spectrometry, J.Chromatogr. A, 998, 133-141 (2003) https://doi.org/10.1016/S0021-9673(03)00645-9
  4. W.W. Bullen, R.A. Miller and R.N. Hayes, Development and Validation of a High-Performance Liquid Chromatography Tandem Mass Spectrometry Assay for Atorvastatin, Ortho-Hydroxy Atorvastatin, and Para-Hydroxy Atorvastatin, and Para-Hydroxy Atorvastatin in Human, Dog, and Rat Plasma, J. Am. Soc. Mass Spectrom., 10, 55-66 (1999) https://doi.org/10.1016/S1044-0305(98)00118-4
  5. M. Jemal, Z. Ouyang, B.C. Chen and D. Teitz, Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometry, Rapid Commun. Mass Spetrom., 13, 1003-1015 (1999) https://doi.org/10.1002/(SICI)1097-0231(19990615)13:11<1003::AID-RCM597>3.0.CO;2-L
  6. G. Bahrami, B. Mohammadi, S. Mirzaeei and A. Kiani, Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detection, J. Chromatogr. B, 826, 41-45 (2005) https://doi.org/10.1016/j.jchromb.2005.08.008
  7. A. Zarghi, A. Shafaati, S.M. Foroutan and A. Khoddam, A simple and rapid HPLC method for the determination of Atorvastatin in human plasma with UV detection and its application to pharmacokinetics, Arzneimittelforschung, 55, 451-454 (2005)
  8. H.R. Shen, Z.D. Li and M.K. Zhong, HPLC assay and phamacokinetic study of atorvastatin in beagle dogs after oral administration of atorvastatin self-microemulsifying drug delivery system, Pharmazie, 61, 18-20 (2006)
  9. B. Mohammadi, N. Rezanour, M.A. Dogaheh, F.G. Bidkorbeh, M. Hashem and R.B. Walker, A stability-indicating high performance liquid chromatography (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 846, 215-21 (2007) https://doi.org/10.1016/j.jchromb.2006.09.007
  10. M.K. Pasha, S. Muzeeb, S.J. Basha, D. Shashikumar, R. Mullangi and N.R. Srinivas, Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies, Biomed. Chromatogr., 20, 282-293 (2006) https://doi.org/10.1002/bmc.561